State Street’s Lucid Diagnostics LUCD Stock Holding History

State Street’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.61M	Buy	2,437,337 +882,756	+57%	+$952K	﹤0.01%	3251
2026 Q1	$1.79M	Buy	1,554,581 +201,626	+15%	+$257K	﹤0.01%	3332
2025 Q4	$1.47M	Buy	1,352,955 +335,168	+33%	+$375K	﹤0.01%	3426
2025 Q3	$1.03M	Buy	1,017,787 +394,719	+63%	+$431K	﹤0.01%	3506
2025 Q2	$717K	Buy	623,068 +578,087	+1,285%	+$747K	﹤0.01%	3553
2025 Q1	$67K	Buy	44,981 +18,000	+67%	+$21.6K	﹤0.01%	4048
2024 Q4	$22.1K	Hold	26,981	–	–	﹤0.01%	4231
2024 Q3	$22K	Hold	26,981	–	–	﹤0.01%	4217
2024 Q2	$22.1K	Buy	26,981 +8,553	+46%	+$7.25K	﹤0.01%	4266
2024 Q1	$14.9K	Buy	18,428 +7,907	+75%	+$10.3K	﹤0.01%	4310
2023 Q4	$14.8K	Hold	10,521	–	–	﹤0.01%	4368
2023 Q3	$12.3K	Hold	10,521	–	–	﹤0.01%	4493
2023 Q2	$14.6K	Hold	10,521	–	–	﹤0.01%	4624
2023 Q1	$14.7K	Hold	10,521	–	–	﹤0.01%	4714
2022 Q4	$14.3K	Hold	10,521	–	–	﹤0.01%	4773
2022 Q3	$16K	Hold	10,521	–	–	﹤0.01%	4853
2022 Q2	$24K	Sell	10,521 -46,172	-81%	-$103K	﹤0.01%	4854
2022 Q1	$190K	Buy	56,693 +11,121	+24%	+$40.6K	﹤0.01%	4401
2021 Q4	$245K	Buy	+45,572	New	+$370K	﹤0.01%	4263

Other funds holding LUCD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.37B AUM 28.49% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

State Street's LUCD Position: Q2 2026 in Review

State Street increased its Lucid Diagnostics (LUCD) stake by 57% in Q2 2026, buying an estimated $952K and bringing the position to 2,437,337 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3251.

State Street first reported a position in LUCD in Q4 2021 and has held it in 19 quarters since. 48 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

State Street held 2,437,337 shares of Lucid Diagnostics worth $2.61M as of Q2 2026.
State Street bought 882,756 Lucid Diagnostics shares in Q2 2026, an estimated $952K.
Lucid Diagnostics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3251 holding.
State Street first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 19 quarters since.
48 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.